Design, Synthesis, and Biological Evaluation of Novel Quercetin Derivatives as PPAR-γ Partial Agonists by Modulating Epithelial-Mesenchymal Transition in Lung Cancer Metastasis

By sjmartinez • April 6, 2023

Ballav S, Bhosale M, Lokhande KB, Paul MK, Padhye S, Swamy KV, Ranjan A, Basu S. Design, Synthesis, and Biological Evaluation of Novel Quercetin Derivatives as PPAR-γ Partial Agonists by Modulating Epithelial-Mesenchymal Transition in Lung Cancer Metastasis. Adv Biol (Weinh). 2023 Apr 5:e2300036. doi: 10.1002/adbi.202300036. Epub ahead of print. PMID: 37017501.

Tags: EMT, Lung cancer, Partial agonist, PPAR-γ, Publications, Pulmonary, Critical Care & Sleep Medicine, Quercetin derivatives, Schiff base

Physical Activity, Genetic Susceptibility, and Risk of Colorectal Cancer in Type 2 Diabetes: A Large Population-Based Cohort Study

Wu Y, Meng M, Liu Y, Zeng R, Feng J, Lian Q, Ma Y, Zhang L, Huang W, Leung FW, Duan C, Sha W, Chen[...]

The Epidemiology of Atopic Dermatitis Among Adults and Adolescents with Alopecia Areata in the United States

Bunick CG, Armstrong AW, Grada A, Soliman AM, Li C, Bristow CC, Khan IA, Lipiszko D, Silverberg JI, Issa NT, Mostaghimi A. The Epidemiology of[...]

Exploring depression treatment response by using polygenic risk scoring across diverse populations

Lapinska S, Pimplaskar A, Shi Z, Ding Y, Frydman-Gani C, Hou K, Venkateswaran V, Boulier K, Olde Loohuis LM, Pasaniuc B. Exploring depression treatment response[...]